RENAL AND BONE SAFETY OF TENOFOVIR ALAFENAMIDE VS TENOFOVIR DISOPROXIL FUMARATE

被引：0
|
作者：
Post, Frank [1 ]
Sax, Paul [2 ]
Saag, Michael [3 ]
Yin, Michael [4 ]
Oka, Shinichi [5 ]
Koenig, Ellen [6 ]
Trottier, Benoit [7 ]
Andrade, Jaime [8 ]
Cao, Huyen [9 ]
Fordyce, Marshall [9 ]
机构：
[1] Kings Coll Hosp London, London, England
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Univ Alabama, Tuscaloosa, AL 35487 USA
[4] Columbia Univ, New York, NY USA
[5] Int Med Ctr Japan, Tokyo, Japan
[6] Dominican Inst Virol Studies, Santo Domingo, Japan
[7] Clin Med Actuel Montreal, Montreal, Dominican Rep
[8] Hosp Civil Guadalajara, Guadalajara, Jalisco, Mexico
[9] Gilead Sci Inc, Foster City, Mexico
来源：
SEXUALLY TRANSMITTED INFECTIONS | 2015年 / 91卷
关键词：
D O I：
10.1136/sextrans-2015-052126.142
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
P99
引用
收藏
页码：A48 / +
页数：2
相关论文
共 50 条
  • [41] Tenofovir alafenamide compared to tenofovir disoproxil fumarate, induces dysglycemia, and dyslipidemia in Wistar rats
    Hurchund, Rajendraparsad
    Sibiya, Sinegugu E.
    Owaga, Bernard O.
    Owira, Peter M. O.
    AIDS, 2024, 38 (13) : 1809 - 1818
  • [42] Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naive chronic hepatitis B
    Lim, Jihye
    Choi, Won-Mook
    Shim, Ju Hyun
    Lee, Danbi
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    LIVER INTERNATIONAL, 2022, 42 (07) : 1517 - 1527
  • [43] COMPARATIVE EFFICACY AND RENAL SAFETY OF ENTECAVIR, TENOFOVIR DISOPROXIL FUMARATE AND TENOFOVIR ALAFENAMIDE FOR HBV-INFECTED CANCER PATIENTS UNDERGOING CHEMOTHERAPY
    Lee, I-Cheng
    Lan, Keng-Hsin
    Su, Chien-Wei
    Chao, Yee
    Lin, Han-Chieh
    Hou, Ming-Chih
    Huang, Yi Hsiang
    HEPATOLOGY, 2021, 74 : 473A - 474A
  • [44] The Use of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide for Preventing Vertical Transmission of Hepatitis B
    Zhu, Lin
    Park, Jaimie
    Deng, You Q.
    Pan, Calvin Q.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2023, 57 (02) : 127 - 138
  • [45] Switching from tenofovir disoproxil fumarate to tenofovir alafenamide: perhaps not as simple as we thought
    Mak, Lung-Yi
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (05): : 420 - 421
  • [46] Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIV
    Moore, Amelia E. B.
    Burns, James E.
    Sally, Deirdre
    Milinkovic, Ana
    Krokos, Georgios
    John, Joemon
    Rookyard, Christopher
    Borca, Alessandro
    Pool, Erica R. M.
    Tostevin, Anna
    Harman, Alyss
    Dulnoan, Dwight S.
    Gilson, Richard
    Arenas-Pinto, Alejandro
    Cook, Gary J. R.
    Saunders, John
    Dunn, David
    Blake, Glen M.
    Pett, Sarah L.
    AIDS, 2024, 38 (04) : 521 - 529
  • [47] Efficacy and safety of switching therapy from tenofovir disoproxil fumarate to tenofovir alafenamide for hepatitis B virus infection
    Kaneko, Shun
    Kurosaki, Masayuki
    Tamaki, Nobuharu
    Itakura, Jun
    Kirino, Sakura
    Watakabe, Keiya
    Osawa, Leona
    Okada, Mao
    Wan, Wang
    Shimizu, Takao
    Higuchi, Mayu
    Takaura, Kenta
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Takahashi, Yuka
    Izumi, Namiki
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E469 - E469
  • [48] SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE TO TENOFOVIR ALAFENAMIDE: ASSESSING THE CHANGE IN RENAL FUNCTION IN HEPATITIS B PATIENTS
    Lee, Minna
    Lee, Susan M. K.
    Bernstein, David Eric
    HEPATOLOGY, 2019, 70 : 316A - 316A
  • [49] Switching tenofovir disoproxil fumarate to tenofovir alafenamide in a real life setting: what are the implications?
    Schwarze-Zander, C.
    Piduhn, H.
    Boesecke, C.
    Schlabe, S.
    Stoffel-Wagner, B.
    Wasmuth, J. C.
    Strassburg, C. P.
    Rockstroh, J. K.
    HIV MEDICINE, 2020, 21 (06) : 378 - 385
  • [50] Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate
    Huhn, Gregory D.
    Shamblaw, David J.
    Baril, Jean-Guy
    Hsue, Priscilla Y.
    Mills, Brittany L.
    Thai Nguyen-Cleary
    McCallister, Scott
    Das, Moupali
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (01):
12345